McMinn Rachel

Chief Executive Officer at NGNE; Chief Strategy Officer at INTERCEPT PHARMACEUTICALS INC

Sold, on record
$615k
Dollars the filings state
Form 4 sales
17
Latest Mar 26, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not stated
    Oct 31, 2016 2016

    Sold 129 shares at $123.82 ($16k)

    McMinn Rachel, Chief Strategy Officer

    Sold 0.9% of holdings ($1.7M position)13,732 shares left1x usual sizeFiling

  2. 2 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusual
    Jan 3, 2017 +64 days

    Sold 816 shares at $103.92 ($85k)

    McMinn Rachel, Chief Strategy Officer

    Sold 5.9% of holdings ($1.4M position)12,916 shares left6.4x usual sizeFiling

  3. 3 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not stated
    Apr 3, 2017 +90 days

    Sold 257 shares at $115.00 ($30k)

    McMinn Rachel, Chief Strategy Officer

    Sold 1.4% of holdings ($2.1M position)17,659 shares left2x usual sizeFiling

  4. 4 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not stated
    May 1, 2017 +28 days

    Sold 114 shares at $113.12 ($13k)

    McMinn Rachel, Chief Strategy Officer

    Sold 0.6% of holdings ($2M position)17,545 shares left0.9x usual sizeFiling

  5. 5 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not stated
    Jul 3, 2017 +63 days

    Sold 257 shares at $121.78 ($31k)

    McMinn Rachel, Chief Strategy Officer

    Sold 1.5% of holdings ($2.1M position)17,288 shares left2x usual sizeFiling

  6. 6 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not stated
    Jul 31, 2017 +28 days

    Sold 130 shares at $123.12 ($16k)

    McMinn Rachel, Chief Strategy Officer

    Sold 0.8% of holdings ($2.1M position)17,158 shares left1x usual sizeFiling

  7. 7 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not stated
    Oct 2, 2017 +63 days

    Sold 283 shares at $58.89 ($17k)

    McMinn Rachel, Chief Strategy Officer

    Sold 1.6% of holdings ($1M position)16,875 shares left2.2x usual sizeFiling

  8. 8 Form 4 sale NGNERoutine
    Mar 26, 2026 +3097 days

    Sold 3,352 shares at $22.07 ($74k)

    McMinn Rachel, Chief Executive Officer

    10b5-1 planSold 0.2% of holdings ($29.7M position)1.3M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by McMinn Rachel
Source
Mar 26, 2026Mar 30, 2026NGNEChief Executive OfficerForm 4 sale3,352$74k0.2%RoutineSEC
Oct 2, 2017Oct 4, 2017INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale283$17k1.6%Plan not statedSEC
Jul 31, 2017Aug 2, 2017INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale130$16k0.8%Plan not statedSEC
Jul 3, 2017Jul 5, 2017INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale257$31k1.5%Plan not statedSEC
May 1, 2017May 3, 2017INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale114$13k0.6%Plan not statedSEC
Apr 3, 2017Apr 5, 2017INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale257$30k1.4%Plan not statedSEC
Jan 3, 2017Jan 5, 2017INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale816$85k5.9%UnusualSEC
Oct 31, 2016Nov 2, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale129$16k0.9%Plan not statedSEC
Aug 1, 2016Aug 2, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale125$22k0.9%Plan not statedSEC
Jul 5, 2016Jul 7, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale106$15k0.8%Plan not statedSEC
May 2, 2016May 4, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale130$19k0.9%Plan not statedSEC
Apr 4, 2016Apr 6, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale104$14k0.7%Plan not statedSEC
Feb 1, 2016Feb 3, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale128$13k1.7%Plan not statedSEC
Jan 4, 2016Jan 5, 2016INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale469$68k5.7%UnusualSEC
Nov 2, 2015Nov 4, 2015INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale125$20k1.5%Plan not statedSEC
Jul 31, 2015Aug 4, 2015INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale127$33k2.9%Plan not statedSEC
May 1, 2015Jul 17, 2015INTERCEPT PHARMACEUTICALS INCChief Strategy OfficerForm 4 sale503$128k10.2%Plan not statedSEC